Mode
Text Size
Log in / Sign up

Probiotic preparations show potential to alleviate chemotherapy-induced oral mucositis severity through immunomodulation and metabolic regulationProbiotics show potential to reduce chemotherapy induced mouth sores

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider probiotic preparations as a promising microbiome-targeted intervention to mitigate chemotherapy-induced oral mucositis.

This systematic review explores the efficacy of probiotic preparations in patients experiencing chemotherapy-induced oral mucositis (CIOM). The scope includes evaluating how these preparations impact clinical severity and underlying mechanisms such as mucosal barrier protection, metabolic regulation, and immunomodulation.

The synthesis indicates that probiotics have demonstrated potential to alleviate CIOM severity. These effects are attributed to competitive colonization of the oral cavity and the modulation of local inflammatory responses. While the review highlights promising application prospects for microbiome-targeted interventions, it notes that specific causal data from individual trials were not detailed in this summary.

A primary limitation noted is that current standard clinical interventions, such as mouth rinses and cryotherapy, have limited efficacy and lack standardized protocols. Consequently, probiotics are presented as a promising alternative or adjunct. However, the evidence suggests these preparations are currently potential candidates rather than established standards of care.

How this fits prior evidence

This finding addresses a gap in managing chemotherapy-induced oral mucositis by exploring microbiome-targeted interventions. It complements prior coverage regarding immunonutrition for radiation-induced oral mucositis as a tolerated supportive measure. While the current review focuses on probiotics for chemotherapy-induced cases, it differs from previous findings where prebiotics and probiotics did not provide clinically important benefits for hemoglobin or ferritin in children.

Chemotherapy often causes oral mucositis, a condition where the lining of the mouth becomes inflamed and develops painful sores. This can make eating and speaking very difficult for patients undergoing cancer treatment. Current methods like mouth rinses have limited success and lack standard rules for use.

Researchers looked at how probiotic preparations might help. These are beneficial bacteria that can compete with harmful germs, regulate metabolism, and balance the immune system. The review found that these probiotics show potential to lessen the severity of oral mucositis by protecting the mucosal barrier and reducing local inflammation.

While the results are promising for managing mouth sores, it is important to note that this is not yet a standard medical treatment. The evidence shows a positive link between probiotic use and reduced symptoms, but more specific data from individual trials is needed to confirm exactly how they work in every patient.

What this means for you:
Probiotics may help reduce the severity of painful mouth sores caused by chemotherapy.

Common questions

What is oral mucositis?

Oral mucositis is a condition where the lining of the mouth becomes inflamed and develops sores. It is often caused by chemotherapy treatments. These sores can make everyday tasks like eating or speaking painful for patients.

How do probiotics help with mouth sores?

Probiotics may help by providing competitive colonization, which means they take up space so harmful germs cannot grow as easily. They also work through metabolic regulation and immunomodulation to reduce inflammation and protect the barrier of the mouth's lining.

Are probiotics a standard treatment for chemotherapy side effects?

While research shows that probiotic preparations are promising for treating oral mucositis, they are not yet established as a standard of care. You should talk to your doctor about whether this option is right for your specific treatment plan.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
Chemotherapy-induced oral mucositis (CIOM) is a prevalent toxic side effect of cancer treatment, severely compromising patients’ quality of life, nutritional intake, and treatment adherence. Its pathogenesis has evolved from the traditional model of simple epithelial damage to a complex pathological process involving the interplay of chemotherapy toxicity, host immunity, and oral microbiota. Research indicates that chemotherapy can disrupt the oral microbiota, promoting the proliferation of pathogenic bacteria and exacerbating damage to the mucosal barrier and local inflammatory responses. Current clinical interventions, such as mouth rinses and cryotherapy, have limited efficacy and lack standardized protocols. In recent years, modulating the oral microbiota has emerged as a promising therapeutic strategy. Probiotic preparations have demonstrated potential in clinical studies to alleviate CIOM severity through mechanisms including competitive colonization, metabolic regulation, and immunomodulation. This review systematically summarizes the clinical manifestations, epidemiological characteristics, pathogenesis, and existing treatment strategies of CIOM. It highlights the critical role of the oral microbiota in CIOM pathogenesis and further outlines the promising application prospects of microbiome-targeted interventions, particularly probiotic preparations, aiming to provide novel insights for CIOM prevention and treatment.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.